<DOC>
	<DOCNO>NCT01528592</DOCNO>
	<brief_summary>Based study show good responsiveness motor versus cognitive symptom Parkinson 's Disease medication , also know dopaminergic treatment , investigator hypothesize comparison rest state network versus medication state Parkinson 's Disease patient show great effect brain network associate motor control .</brief_summary>
	<brief_title>PharmacoMRI Parkinson Disease</brief_title>
	<detailed_description>Subject participation include two 25-30 minute MRI scan . The subject arrive `` '' state ( PD medication withhold approximately 12 hour prior scan ) . Following initial scan , subject receive 125 % usual daily morning dose PD medication calculate levodopa dose equivalent ( LDE ) give carbidopa-levodopa . The subject wait hour allow medication begin work . During time subject complete cognitive assessment , questionnaire regard history current state PD , motor assessment . The subject undergo second MRI scan approximately 25-30 minute . The subject complete second MRI scan free leave . The entire study approximately 2 1/2 hour long .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<criteria>Idiopathic Parkinson 's Disease ( PD ) Older 30 year age time diagnosis Hoehn Yahr stage great equal 2.5 PD duration great 3 year Stable regimen PD medication least 2 week prior image PD medication include carbidopalevodopa Patients diagnosis neurodegenerative condition Patients unwilling unable give inform consent Contraindications ( cardiac pacemaker , etc . ) inability ( e.g. , claustrophobia ) undergo MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>